How Has the Antibody Discovery Market Evolved Historically and What is its Current Size?
The antibody discovery market has seen considerable growth due to a variety of factors.
• The size of the antibody discovery market has expanded swiftly in the recent past. It is projected to increase from $8.96 billion in 2024 to $9.87 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%.
The historical growth is related to the upsurge in funding for drug discovery, escalating investments in research and development activities, and the existence of numerous healthcare research centers and academic institutions.
What Is The Projected Growth Of The Antibody Discovery Template Market?
The antibody discovery market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for antibody discovery is anticipated to swiftly expand in the coming years, reaching a value of $14.6 billion by 2029 with a compound annual growth rate (CAGR) of 10.3%.
This expected growth during the projected period is primarily due to an escalating need for antibody drug discovery services and platforms, an increase in funds allocated for the creation of innovative technologies, a rising demand for precision therapeutics, and an expansion in the applications of antibodies beyond traditional therapeutic roles. Key trends to watch out for during this forecast period include heightened research and development efforts, a growing demand for monoclonal antibodies, a boost in the adoption of cutting-edge technologies, growing need for targeted therapeutics, and the creation of new antibody formats.
What Are The Key Drivers Fueling Growth In The Antibody Discovery Market?
The antibody discovery market's expansion is predicted to be driven by an increasing demand for precision therapeutics. Also known as personalized therapeutics, precision therapeutics entails tailor-making medical treatments and interventions based on the specific characteristics of each patient. Antibody discovery plays a crucial role in this process, facilitating the creation of targeted therapies like monoclonal antibodies. These are engineered to interact specifically and accurately with molecules or cells associated with disease, leading to more personalized and effective treatment. To illustrate, the US-based Personalized Medicine Coalition disclosed that the Food and Drug Administration’s Center for Drug Evaluation and Research approved 37 new molecular entities in 2022. Of these, about 34%, or 12, are recognized as personalized medicines by the Personalized Medicine Coalition. Hence, the burgeoning demand for precision therapeutics is expected to bolster the antibody discovery market's growth.
What Are The Principal Market Segments In The Global Antibody Discovery Industry?
The antibody discovery market covered in this report is segmented –
1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory
Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques
Pre-Book The Antibody Discovery Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Antibody Discovery Market?
Leading firms in the antibody discovery market, such as SwiftPharma BV, are embracing innovative technologies like AI-based computational antibody drug discovery platforms to enhance antibody development's precision and efficiency. This cutting-edge platform employs artificial intelligence and computational methodologies to fast-track the identification and optimization of therapeutic antibodies. In October 2023, SwiftPharma BV, a Belgium-based company specializing in the development of recombinant proteins from a specific plant-based system, announced the launch of its AI-powered antibody discovery platform. This revolutionary platform merges artificial intelligence, big data, machine learning, and phage display techniques, expediting the prediction of antibody-antigen binding with high-specificity and high-affinity. Drawing parallels with natural language processing, this platform generates a broad spectrum of antibody variants, thereby enabling SwiftPharma to efficiently build extensive antibody libraries. This state-of-the-art system significantly shortens the time taken for the discovery of potential antibody drugs.
Who Are the Key Players In The Antibody Discovery Market?
Major companies operating in the antibody discovery market report are:
• Danaher Corporation
• Eurofins Scientific
• Sartorius AG
• Charles River Laboratories
• Bruker Corporation
• WuXi Biologics
• Genmab A/S
• Evotec
• Cambrex corporation
• ChemPartner
• Aragen life science Pvt ltd
• Genscript Technology Corporation
• Biocytogen
• Alcami Corporation Inc
• Twist Bioscience
• BioDuro-Sundia
• Fairjourney Biologics S.A
• Harbour BioMed
• Rockland Immunochemicals
• Creative Biolabs
• Synbio technologies
• ImmunoPrecise
• Ablexis
• Myrio Therapeutics
• Antibody Solutions
• MabSilico
What Are The Regional Insights Into The Antibody Discovery Market?
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
